Pfizer Inc and BioNTech SE said Wednesday that real-world data from Israel suggests that their Covid-19 vaccine is 94 percent effective in preventing asymptomatic infections, meaning the vaccine could significantly reduce transmission.
The companies also said the latest analysis of the Israeli data shows the vaccine was 97 percent effective in preventing symptomatic disease, severe disease and death. That is basically in line with the 95 percent efficacy Pfizer and BioNTech reported from the vaccine's late-stage clinical trial in December.
Read more:
https://www.nbcnews.com/health/health-news/pfizer-covid-vaccine-cuts-transmission-coronavirus-new-real-world-study-n1260542?fbclid=IwAR1Q4xf9g4in5rysnd3Y-4BUFQ-QxiBBPXL9Fm0_PkAa4znqzNw_q3RuQ5c analysis also shows real-world evidence of the vaccine's effectiveness against a highly infectious variant of Covid-19 first discovered in Britain.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου